We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JOET icon
3651
Virtus Terranova US Quality Momentum ETF
JOET
$252M
$23K ﹤0.01%
937
+136
+17% +$3.69K
KORE
3652
DELISTED
KORE Group Holdings
KORE
$23K ﹤0.01%
+1,517
New +$33.9K
LEVI icon
3653
Levi Strauss
LEVI
$8.63B
$23K ﹤0.01%
1,445
+1,133
+363% +$20.5K
LFVN icon
3654
LifeVantage
LFVN
$81.9M
$23K ﹤0.01%
5,224
+4,990
+2,132% +$21.8K
NFE icon
3655
New Fortress Energy
NFE
$93M
$23K ﹤0.01%
594
+574
+2,870% +$24.7K
NSYS icon
3656
Nortech Systems
NSYS
$35.6M
$23K ﹤0.01%
1,632
+1,606
+6,177% +$18.9K
NUGT icon
3657
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.16B
$23K ﹤0.01%
663
-541
-45% -$29.4K
OCUL icon
3658
Ocular Therapeutix
OCUL
$2.22B
$23K ﹤0.01%
5,651
+4,228
+297% +$16K
OPAD icon
3659
Offerpad Solutions
OPAD
$21.8M
$23K ﹤0.01%
+70
New +$47K
PERI icon
3660
Perion Network
PERI
$384M
$23K ﹤0.01%
1,235
-1,795
-59% -$37.2K
RAPT
3661
DELISTED
RAPT Therapeutics
RAPT
$23K ﹤0.01%
161
-48
-23% -$6.4K
SAN icon
3662
Banco Santander
SAN
$211B
$23K ﹤0.01%
8,233
-11,189
-58% -$34.2K
SEAT icon
3663
Vivid Seats
SEAT
$80.5M
$23K ﹤0.01%
153
+71
+87% +$12.8K
SGU icon
3664
Star Group
SGU
$411M
$23K ﹤0.01%
2,538
-791
-24% -$8.15K
SKIL icon
3665
Skillsoft
SKIL
$78.4M
$23K ﹤0.01%
328
-142
-30% -$14.6K
SNBR
3666
DELISTED
Sleep Number
SNBR
$23K ﹤0.01%
747
+541
+263% +$23K
SNCR
3667
DELISTED
Synchronoss Technologies
SNCR
$23K ﹤0.01%
2,146
+819
+62% +$10.4K
SRDX
3668
DELISTED
Surmodics
SRDX
$23K ﹤0.01%
614
+260
+73% +$10.1K
SSP icon
3669
E.W. Scripps
SSP
$310M
$23K ﹤0.01%
1,810
-6,939
-79% -$111K
TBPH icon
3670
Theravance Biopharma
TBPH
$878M
$23K ﹤0.01%
2,517
+983
+64% +$9.06K
VLGEA icon
3671
Village Super Market
VLGEA
$638M
$23K ﹤0.01%
1,009
+308
+44% +$7.26K
WNC icon
3672
Wabash National
WNC
$509M
$23K ﹤0.01%
1,710
+888
+108% +$12.8K
LUCK
3673
Lucky Strike Entertainment
LUCK
$930M
$23K ﹤0.01%
2,138
-1,005
-32% -$10.7K
BTTX
3674
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$23K ﹤0.01%
14,627
+14,440
+7,722% +$24.2K
BVH
3675
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$23K ﹤0.01%
915
-121
-12% -$3.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.